Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis
Sponsor: BioClin BV
Summary
This is a randomized, double-blind, placebo-controlled clinical investigation. The objective of the study is to confirm the efficacy of Multi-Gyn ActiGel Plus to treat BV as compared to a placebo control. Treatment arm 1: Multi-Gyn ActiGel Plus Treatment arm 2: placebo gel Both the Multi-Gyn ActiGel Plus and the placebo will be applied twice a day for 7 consecutive days. Visit 2 will be performed at 3 weeks after start of treatment A phone call will take place, at 5 weeks after start of treatment for subject with clinical cure at Visit 2. The total duration per subject is estimated 5 weeks and the total study duration is 13 months. Sample size is 100 subjects per treatment arm.
Official title: A Double-blind, Randomized, Placebo-controlled Study to Confirm the Efficacy and Safety of Multi- Gyn ActiGel Plus for Treatment of Bacterial Vaginosis
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-06-11
Completion Date
2026-12-01
Last Updated
2025-09-29
Healthy Volunteers
No
Conditions
Interventions
vaginal gel
The placebo gel is a non-buffered gel. The active device is an acidic gel.
Locations (1)
Praxis Dr. Peters
Hamburg, Germany